This article has been updated with information from the Wadsworth Center of the New York State Department of Health.
NEW YORK – Labs and companies across the world are betting on alternative specimen types for COVID-19 testing – such as saliva, nasal swabs, or oral solution – to increase the speed and convenience of sample collection, aiming to overcome one of the challenges in rapidly scaling up testing efforts.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
